ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,051, issued on Oct. 7, was assigned to Vivozon Inc. (Yongin-si, South Korea).

"Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof" was invented by Dae Kyu Choi (Yongin-si, South Korea), Hyo Jin Kim (Yongin-si, South Korea), Mi Seon Bae (Yongin-si, South Korea), Jin Choi (Seoul, South Korea), Hyun Jin Heo (Yongin-si, South Korea), Yong Seok Lee (Yongin-si, South Korea), Geon Ho Lee (Yongin-si, South Korea), Mi Yon Shim (Yongin-si, South Korea), Jin Sun Park (Yongin-si, South Korea) and Han Mi Lee (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a dual modulator of mGluR5 and 5-HT2AR (5-HT2A receptor), and...